A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
Andrew J Vickers, Angel M Cronin, Gunnar Aus et al. · BMC Medicine · 2008 · Randomised trial
Full textCC BY